Collegium Pharmaceutical has tapped an appropriately glitzy star as the face of a new campaign spotlighting the bright side of life with attention-deficit/hyperactivity disorder. More: Collegium enrolls Paris Hilton in Jornay PM push encouraging ADHD community to 'Embrace Your Sparkle'
read moreBioDuro, headquartered in California, has set up a new joint venture with Taiwan drug ingredients manufacturer, Cenra API Solutions. The new enterprise will see Cenra’s commercial-scale facility in Taipei folded into BioDuro’s production network. More: BioDuro enters Taiwan joint venture,
read moreThe company has been pressing the FDA to hold a formal hearing on its proposed jet lag label expansion for Hetlioz since it was first snubbed way back in 2019. More: FDA answers Vanda's yearslong call for public hearing on
read more
First‑in‑human phase 1/2a study launches in China and the US targeting advanced cancers More: HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours Source: News
read more
New funding will support the phase 2 expansion trial of THEO-260 More: Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study Source: News
read moreThe primary growth drivers in Bayer’s pharma sector—Nubeqa and Kerendia—are performing even better than the company anticipated and their momentum is expected to continue in 2026. But that won’t lead to growth of Bayer’s pharma business overall this year as
read more© 1994 - 2026 B.M. Pharmaceuticals